This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Top 5 Small-Cap Stocks for June 26

David Peltier will be on Stockpickr Answers on June 26 to respond to investing and trading questions posed by members of the Stockpickr community. Not a member? Join the Stockpickr community today -- for free.

TSC Ratings Ratings provides exclusive stock, ETF and mutual fund recommendations using proprietary tools. Our "safety-first" approach aims to reduce risk while achieving performance on a total return basis.

Each business day, we compile a list of the top five stocks in one of five categories -- fast-growth, all-around value, large-cap, mid-cap and small-cap.

Today, small-cap stocks are in the spotlight. These companies have market capitalizations between $50 million and $500 million and receive "buy"-ratings from our proprietary quantitative model, which considers more than 60 factors. They are ordered by their potential to appreciate.

Hawkins (HWKN - Get Report) blends and distributes bulk and specialty chemicals for water treatment and industrial and pharmaceutical use. We have rated Hawkins buy since January 2003.

Fiscal fourth-quarter revenue ascended 32% year over year to $68 million as net income surged 194% to $5.09 million and EPS climbed 182% to 48 cents. Gross, operating and net margin ascended 225, 694 and 413 basis points to 22%, 11% and 7.5%, respectively. Return on equity increased 908 basis points to 17%, and return on equity surged 1,186 basis points to 23%. The company has zero debt and ample liquidity, as reflected by a quick ratio of 2.1.

Shares of Hawkins have ascended 43% in 2009, far outperforming the Dow Jones Industrial Average and the S&P 500. Yet the stock trades at a price-to-earnings ratio under 10, indicating a sizable discount to the market average of 14 and the chemicals peer average of 20. The stock offers a weak .26% dividend yield.

Balchem (BCPC - Get Report) provides specialty performance ingredients and products for the food, nutrition, feed, pharmaceutical and medical sterilization industries. We have rated Balchem buy since June 18, 2007.
1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BCPC $68.49 1.20%
DMND $40.48 -2.60%
HWKN $41.02 0.34%
TMP $62.71 2.90%
VLGEA $25.92 -1.90%


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs